Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.

The protein kinase C inhibitor CGP 41251, a staurosporine derivative with antitumor activity, reverses multidrug resistance

Abstract

Multidrug resistance (MDR) is frequently associated with overexpression of a 170-kDa P-glycoprotein (Pgp). Data suggest altered protein kinase C (PKC) activity in cells expressing the multidrug-resistant phenotype. The staurosporine derivative CGP 41251, an experimental anticancer drug, has been shown to exert selectivity for inhibition of protein kinase C activity and to exhibit antitumor activity in vitro and in vivo. Here we show that CGP 41251 is also able to reverse MDR. After treatment of the multidrug-resistant human lymphoblastoid cell line CCRF-VCR1000 with 500 nM Adriamycin, cell proliferation was reduced to 81% of untreated controls. A combination of 500 nM Adriamycin with a non-toxic concentration of 150 nM CGP 41251 (IC50 for inhibition of cell proliferation 420 nM CGP 41251) inhibits cell proliferation of CCRF-VCR1000 cells to 29% of untreated controls. In sensitive CCRF-CEM cells no enhancement of Adriamycin-induced cytotoxicity was observed upon addition of 150 nM CGP 41251. Strong synergism of the inhibition of cell proliferation was also observed after concomitant treatment of KB-8511 cells with CGP 41251 and Vinblastine or Adriamycin. Drug-sensitive KB-31 cells could not be further sensitized to Adriamycin or Vinblastine with CGP 41251 doses above 100 nM. Pretreatment with 50-1000 nM CGP 41251 for 30 min led to a dose-dependent increase in the intracellular accumulation of rhodamine 123, a substrate of P-glycoprotein. Treatment of multidrug-resistant CCRF-VCR1000 cells with CGP 41251 for 10 min was sufficient to inhibit the efflux of rhodamine 123. Preincubation with CGP 41251 for 12 or 24 hr did not alter multidrug resistance gene (mdrI)-mRNA levels. CGP 41251, a drug with antitumor efficacy in experimental systems, might offer an attractive combination partner for the treatment of tumors expressing the MDR phenotype.

Overview

Integrity signals

Registry

Crossref · 10.1002/ijc.2910570119

Cites

36 of 36 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

1 retracted

Research works printed but not linked: 5

  1. Benson A. B., 1985, Phase I study of vinblastine and verapamil given hy concurrent iv infusion, Cancer Treat. Rep., 69, 795
  2. Chaudhary P. M., 1992, Activation of MDRI (P‐ glycoprotein) gene expression in human agonists, Oncology Res., 4, 281
  3. Dong Z., 1991, In vitro model for intrinic drug resistance: effects of protein kinnse C activators on chemosensitivity of cultured human colon cancer cells, Mol. Phannacol., 19, 563
  4. Fidler I. J., 1993, Role of the organ environment in the pathogenesis of cancer metastasis, Proc. Amer. Assoc. Cancer Res., 34, 570
  5. Matter A., 1991, A pharmacological approach to growth regulation of breast cancer cells, Pezcoller Foundation Symp., 2, 227

Cited by

See all 72

Metadata

Authors
Utz, I., Hofer, S., Regenass, U., Hilbe, W., Thaler, J., Grunicke, H., & Hofmann, J.
Affiliations
Universität Innsbruck (AT)
Corresponding author
Hofmann, Johann
Venue
International Journal of Cancer
Publisher
Wiley
Published
1994-04
Volume
57
Issue
1
Pages
104-110
ISSN
  • 0020-7136 (ISSN-L)
  • 1097-0215
OpenAlex
W2057939330
Cited by
72
References
36
Citations by year
2024: 1 · 2023: 2 · 2021: 1 · 2019: 2 · 2018: 2 · 2017: 2 · 2016: 1 · 2014: 2 · 2012: 1
FWCI
3.31
Type
journal article
Language
en
Open access
closed
Locations
  • International Journal of Cancer (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
  • Health Sciences › Medicine › Microbiology (medical) › Antibiotic Resistance in Bacteria
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
Keywords
staurosporine derivatives, PKC inhibitors, multidrug resistance reversal, P-glycoprotein, multidrug resistance gene 1, doxorubicin, vinblastine, drug efflux inhibition, rhodamine 123 accumulation, synergistic drug combination, lymphoblastoid cell lines, MDR1 mRNA
MeSH terms
Alkaloids, Antineoplastic Agents, Carrier Proteins, Doxorubicin, Drug Resistance, Humans, KB Cells, Lymphocytes, Membrane Glycoproteins, Protein Kinase C, Rhodamines, Tumor Cells, Cultured, Vincristine, Gene Expression, Staurosporine, Rhodamine 123, ATP Binding Cassette Transporter, Subfamily B, Member 1

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.